"Biomarkers, Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS.
| Descriptor ID |
D014408
|
| MeSH Number(s) |
D23.101.140
|
| Concept/Terms |
Biomarkers, Tumor- Biomarkers, Tumor
- Tumor Biomarkers
- Markers, Biological Tumor
- Tumor Markers, Biological
- Markers, Tumor Metabolite
- Tumor Metabolite Markers
- Metabolite Markers, Tumor
- Marker, Tumor Metabolite
- Metabolite Marker, Tumor
- Tumor Metabolite Marker
- Tumor Markers, Biologic
- Biologic Tumor Markers
- Markers, Biologic Tumor
- Marker, Biologic Tumor
- Biologic Tumor Marker
- Tumor Marker, Biologic
- Biochemical Tumor Markers
- Markers, Biochemical Tumor
- Marker, Biochemical Tumor
- Biochemical Tumor Marker
- Tumor Marker, Biochemical
- Tumor Markers, Biochemical
- Carcinogen Markers
- Markers, Carcinogen
- Markers, Neoplasm Metabolite
- Neoplasm Metabolite Markers
- Marker, Neoplasm Metabolite
- Metabolite Marker, Neoplasm
- Neoplasm Metabolite Marker
- Metabolite Markers, Neoplasm
- Biological Tumor Markers
- Biological Tumor Marker
- Tumor Marker, Biological
- Marker, Biological Tumor
Markers, Tumor- Markers, Tumor
- Tumor Markers
- Biomarkers, Cancer
- Cancer Biomarkers
|
Below are MeSH descriptors whose meaning is more general than "Biomarkers, Tumor".
Below are MeSH descriptors whose meaning is more specific than "Biomarkers, Tumor".
This graph shows the total number of publications written about "Biomarkers, Tumor" by people in this website by year, and whether "Biomarkers, Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 3 | 0 | 3 |
| 1998 | 6 | 3 | 9 |
| 1999 | 7 | 2 | 9 |
| 2000 | 5 | 1 | 6 |
| 2001 | 7 | 2 | 9 |
| 2002 | 4 | 6 | 10 |
| 2003 | 11 | 15 | 26 |
| 2004 | 12 | 6 | 18 |
| 2005 | 15 | 15 | 30 |
| 2006 | 17 | 10 | 27 |
| 2007 | 18 | 11 | 29 |
| 2008 | 18 | 13 | 31 |
| 2009 | 21 | 21 | 42 |
| 2010 | 20 | 22 | 42 |
| 2011 | 14 | 26 | 40 |
| 2012 | 21 | 17 | 38 |
| 2013 | 27 | 23 | 50 |
| 2014 | 27 | 19 | 46 |
| 2015 | 37 | 22 | 59 |
| 2016 | 34 | 30 | 64 |
| 2017 | 39 | 23 | 62 |
| 2018 | 43 | 25 | 68 |
| 2019 | 32 | 33 | 65 |
| 2020 | 39 | 26 | 65 |
| 2021 | 41 | 32 | 73 |
| 2022 | 2 | 33 | 35 |
| 2023 | 3 | 13 | 16 |
| 2024 | 12 | 26 | 38 |
| 2025 | 27 | 29 | 56 |
| 2026 | 6 | 1 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biomarkers, Tumor" by people in Profiles.
-
Frequent synaptophysin expression in SMARCA4-deficient undifferentiated carcinoma of the oesophagus: a diagnostic pitfall with therapeutic implications. J Clin Pathol. 2026 Mar 19; 79(4):229-237.
-
Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosis. Hepatol Commun. 2026 Mar 01; 10(3).
-
GATA3 Is Underexpressed in Penile Neoplasia: Potential Implications in Diagnosis and Pathogenesis. Am J Surg Pathol. 2026 Apr 01; 50(4):416-426.
-
Tumor-specific immune responses and biomarkers in pediatric patients with high-risk Hodgkin lymphoma. Blood Adv. 2026 Jan 13; 10(1):183-191.
-
Multiomic Factor Analysis for Pathologic Complete Response after Pembrolizumab + Trastuzumab + Pertuzumab in HER2-Enriched Early Breast Cancer: WSG-Keyriched-1 Trial. Clin Cancer Res. 2026 Jan 06; 32(1):214-223.
-
Personalizing therapies over the course of hormone receptor-positive/HER2-negative metastatic breast cancer. CA Cancer J Clin. 2026 Jan-Feb; 76(1):e70055.
-
Surface Marker Identification to Capture Live Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer. Cancer Res Commun. 2026 Jan 01; 6(1):115-129.
-
17?-Hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in Denmark. Breast Cancer Res. 2025 Dec 30; 28(1):28.
-
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III Melanoma. Clin Cancer Res. 2025 Dec 15; 31(24):5225-5236.
-
Multi-omic analysis of hepatocellular carcinoma reveals aberrant cis-regulatory changes and dysregulated retrotransposons with prognostic potential. Commun Biol. 2025 Dec 13; 8(1):1792.